Vincent Colicchio is vice president of supply chain and external manufacturing for Dr. Reddy’s Laboratories North America. In this interview he discusses optimizing the industry’s workforce, facilities and processes, including measures to avoid drug shortages. CDR: What do you see as workforce needs and training for generic drug manufacturing? COLICCHIO: For generic drug manufacturing, there
What’s going on at CVS? Are these dramatic moves that were announced recently by the Woonsocket, R.I.-based drug chain the preface to a new beginning or an admission that all is not running as smoothly as the chain drug industry and one of its premier retailers had hoped? That’s the question most on industry minds
The Urban Institute just issued a study that sheds new light on the persistent and vexing problem of access to prescription drugs in the U.S. Working with data from a recent Medical Expenditure Panel Survey, researchers concluded that in the pre-COVID years 2018-2019 almost 13 million American adults either did without needed medications or held
FRISCO, Texas – Urban Hydration is ready to make news again. The trailblazing beauty brand will virtually broadcast its Second Annual Business Partner Awards on December 14, 2021 at 10:30 ET. ‘We are so impressed by the winners this year. They really are the best of the best in retail beauty and we are honored
With our iA customers, we see how pharmacy providers are increasingly competing to offer the best experience to attract and retain patients and customers. An important aspect of this commitment is spending time with patients and giving patients the choice of when, where and how they receive their prescriptions. The introduction of therapy management solutions
Scientists researched, developed and tested COVID-19 vaccines in record time — then the race to manufacture and deliver them to health care sites around the world began. To save lives, the vaccination program was rapidly rolled out. On the front line, pharmacists, nurses and doctors worked day and night to vaccinate the most vulnerable patients
It has been a big fall for interchangeable biologics. President Biden’s Executive Order 14036, “Promoting Competition in the American Economy” directed the Department of Health and Human Services (and the Food and Drug Administration), and HHS subsequently published its “Comprehensive Plan for Addressing High Drug Prices.” Interchangeable biosimilars are front and center in both of
Like many other policies intended to curb the spread of COVID-19, the Biden administration’s emergency temporary standard (ETS), which requires companies with 100 or more employees to ensure that members of their workforce are immunized or undergo weekly testing, has become a flashpoint. In addition to expected resistance from many Republicans, some business groups, including
This newspaper has no more committed — and significant — supporter than Scott Emerson. To those few in our retail audience who, unfortunately for them, have not yet taken advantage of the many benefits Emerson has to offer, some background information is in order. Scott Emerson is the founder, chief executive and primary motivator of
Late last month, the editors of Mass Market Retailers, sister publication of Chain Drug Review, hosted a reception and dinner in Chicago. The occasion was to recognize several of the growing number of women who are starting to lead and shape mass market retailing. The event was noteworthy for several reasons. For openers, there were
In laying out her vision for the future of Walgreens Boots Alliance at the company’s investor day last month, chief executive officer Roz Brewer framed the strategy in personal terms. Recalling her mother’s final illness a decade ago, Brewer talked about the daunting complexity and wastefulness of health care in America, and how WBA is
With the exception of wartime, concerns about the supply chain have never in living memory been more pressing than they are today. Americans, long accustomed to quick, easy access to relatively low-priced goods, have been confronted with a unusually high number of out-of-stocks since the arrival of COVID-19 and, based on the number of container
NEW YORK — In an effort to keep reining in the pandemic, the Biden administration will invest $1 billion to quadruple the national supply of at-home COVID-19 tests by December. In addition, it is expanding the number of free community-based test sites to 30,000 nationwide, including 20,000 in pharmacies. The White House’s announcement of the
One such gathering that has recently emerged as a go-to event is the annual meeting sponsored, assembled, coordinated and managed by the Emerson Group, a leading and much-emulated organization that excels at bringing buyers and sellers together to meet, exchange ideas, swap secrets and, not incidentally, buy and sell products. A recent adjunct to this